申请人:MEDIVIR AB
公开号:US20170267705A1
公开(公告)日:2017-09-21
The invention provides compounds of the formula:
R
1
is OR
11
, or NR
5
R
5′
;
R
2
is H or F;
R
5
is H, OH, C
1
-C
6
alkyl, OH, C(═O)R
6
, O(C═O)R
6
or O(C═O)OR
6
;
R
5′
is H or C
1
-C
6
alkyl;
R
6
is C
1
-C
6
alkyl or C
3
-C
7
cycloalkyl;
R
13
is H, phenyl, pyridyl, benzyl, indolyl or naphthyl wherein the phenyl, pyridyl, benzyl, indolyl and naphthyl is optionally substituted with 1, 2 or 3 R
22
;
and the other variables are as defined in the claims,
which are of use in the treatment of cancer, and related aspects.